Scientific Sessions
Scientific Sessions
  • Program
  • #AHA24
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Topics
  • Late-Breaking Science
  • Daily Coverage
  • Industry Highlights
  • Photo Gallery
  • Journeys
Resources
  • Program
  • #AHA24
User Tools
  • Privacy Policy
  • Terms & Conditions
  • Accessibility Statement
Twitter X icon Facebook iconInstagram iconYouTube iconPinterest iconLinkedIn icon
Nov 18th, 2024

Streamlining the pathway to publish cardiovascular research

Starting in 2025, research authors will have the option to select a seamless transfer of their manuscript between NEJM and Circulation.


Aha24 Nejm Web Image

The American Heart Association (AHA) is thrilled to announce a new collaboration between the New England Journal of Medicine (NEJM) and the AHA’s flagship journal Circulation. In January 2025, research authors will have the option to select a seamless transfer of their manuscript between NEJM and Circulation.

This pilot program leverages the expertise of the journals’ world-class editors and peer reviewers to streamline the publication of novel cardiovascular research.

NEJM is the most widely read and cited general medicine journal in the world, and coupled with Circulation’s stature in cardiology this arrangement helps to expedite the submission process for authors, simplifying the publication pathway for high-impact cardiovascular articles. This collaboration aims to strengthen, diversify and improve the quality of research published in both journals, providing greater benefits to authors and readers.

Together, the journals are set to amplify the sharing of innovative cardiovascular research, speed the publication of practice-changing science and address pressing health challenges, while underscoring each organization’s commitment to improving global health outcomes for the benefit of patients everywhere.

Interesting Stories
Unmet Needs in Hypertension Toolkit
Sponsored by Medtronic
Unmet Needs in Hypertension Toolkit
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Sponsored by Medscape
CME Gameshow Style Sympo: Navigating New Paradigms in Thrombosis Management
Lp(a) and Peripheral Artery Disease Toolkit
Sponsored by Kaneka Corporation
Lp(a) and Peripheral Artery Disease Toolkit
Screening for Kidney Disease to Reduce CVD Risk
Sponsored by Bayer
Screening for Kidney Disease to Reduce CVD Risk
More Content
Health Tech winners
AHA24
AI medical company wins global health tech competition at #AHA24
Nov 20th, 2024
241116 American Heart Association Keynote 0080
AHA24
LBS 08: Advances in lipid therapeutics
Nov 20th, 2024
Crowd shot
AHA24
LBS 07: New approaches to managing AFib
Nov 20th, 2024
Stage shot
AHA24
LBS 06: Medical therapy for heart failure
Nov 20th, 2024
Stage shot
AHA24
LBS 05: Innovation in prevention
Nov 20th, 2024
French Quarter balcony shot
AHA24
Save the date for #AHA25 in New Orleans
Nov 20th, 2024
Asgar headshot
AHA24
Managing patients with symptomatic mitral or tricuspid regurgitation
Nov 18th, 2024
Nancy Brown headshot
AHA24
AHA CEO: Driving breakthroughs
Nov 18th, 2024
Shot of speakers
AHA24
Environmental crises call for more CV research
Nov 18th, 2024
Churchwell
AHA24
Wake-up call: Heeding global risk factors
Nov 18th, 2024
Casadei headshot
AHA24
Dissecting the complex relationship between atrial cardiomyopathy and stroke
Nov 18th, 2024
Stage shot
AHA24
LBS 04: Coronary and valvular heart disease
Nov 18th, 2024